APA (7th ed.) Citation

F, L., DF, A., W, K., A, V., D, Y., L, F., . . . É, M. (2016). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause (New York, N.Y.), 23(3), 243. https://doi.org/10.1097/GME.0000000000000571

Chicago Style (17th ed.) Citation

F, Labrie, et al. "Efficacy of Intravaginal Dehydroepiandrosterone (DHEA) on Moderate to Severe Dyspareunia and Vaginal Dryness, Symptoms of Vulvovaginal Atrophy, and of the Genitourinary Syndrome of Menopause." Menopause (New York, N.Y.) 23, no. 3 (2016): 243. https://doi.org/10.1097/GME.0000000000000571.

MLA (9th ed.) Citation

F, Labrie, et al. "Efficacy of Intravaginal Dehydroepiandrosterone (DHEA) on Moderate to Severe Dyspareunia and Vaginal Dryness, Symptoms of Vulvovaginal Atrophy, and of the Genitourinary Syndrome of Menopause." Menopause (New York, N.Y.), vol. 23, no. 3, 2016, p. 243, https://doi.org/10.1097/GME.0000000000000571.